Compiled 2026-09-26Data through 2026-01-252 min read
Dated source-based research · No live market data

Research summary

A two-period review of NVDA revenue, profitability and cash conversion; reported revenue growth was 65.47%.

Period comparison

FY2026 ended 2026-01-25; the prior observation ended 2025-01-26. Revenue moved from USD 130.497 billion to USD 215.938 billion. These are annual periods, not quarterly earnings or trailing-twelve-month estimates.

Earnings bridge

Net income moved from USD 72.880 billion to USD 120.067 billion. Operating income moved from USD 81.453 billion to USD 130.387 billion. Net margin moved from 55.85% to 55.60%. A margin change identifies an outcome; its causes require management discussion and footnotes.

Cash-flow cross-check

Operating cash flow was USD 64.089 billion in the earlier period and USD 102.718 billion in the later period. Selected free cash flow was not available and not available, respectively. Working-capital timing can cause earnings and cash to diverge.

Interpretation and limits

A rise in reported revenue does not by itself identify organic growth. A difference in EPS can reflect share-count changes as well as operating performance. No causal claim is made from these aggregate figures.

Valuation context

An earnings comparison provides a historical denominator, not a price target. A dated market price is deliberately absent from this static release.

What to monitor

Revenue mix, research spending, inventory and cash conversion.

Risks and uncertainties

Customer concentration, product transitions, export restrictions and the durability of capital spending.

Sources & dates